CMS Bio
- Biotech or pharma, therapeutic R&D
CMS bio is the R&D arm of CMS pharma, a leading HKEX listed pharma company (hk.0867).
https://web.cms.net.cn/en/innovation/pipeline/
Rxilient is the ex-China commercial arm within CMS pharma, a leading HKEX listed pharma company (hk.0867), covering APAC ex-China commercialization.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}